Carolyn Diemchau Le, MD
Family Practice · Menlo Park
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Offices
- 3
Offices
3 locations · University Healthcare Alliance · 334 clinicians in this group
Hospitals listed: 053137 · Alta Bates Summit Medical Center · Alta Bates Summit Medical Center - Alta Bates Camp · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Le’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A140160 · Current
Licensed to practise in California · since 2016 · expires 2027-10-31 · St. George'S University School of Medicine. Board flags: Citation Issued.
Public record actions
| 2025-06-04 | Citation | Section 1338(c) of Title 16, California Code of Regulations · $1,000 |
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Alta Bates Summit Medical CenterOakland, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Death rate among surgical inpatients with serious treatable complications: 130.09 (87.72 to 172.46) · 109 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.274, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.227, Oct 2024 – Sep 2025
- Alta Bates Summit Medical Center - Alta Bates CampBerkeley, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.298, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Alta Bates Summit Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 4 better, 3 the same, 0 worse of 7 measures. Readmissions: 3 better, 6 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 130.09 (87.72 to 172.46) · 109 cases | Better | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.274 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.227 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1 (0.06 to 1.94) · 1,209 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.88 (0.6 to 1.16) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.9 · 105 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.8 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 447 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.7 · 341 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.2 · 381 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 2,811 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.31) · 7,167 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,659 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.93 (0.92 to 4.94) · 1,668 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.25 (0 to 2.75) · 580 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.67 (1.19 to 4.15) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.17 (0.33 to 12.02) · 633 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 8.11 (4.67 to 11.55) · 619 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.07) · 309 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.39 (0 to 0.96) · 6,085 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.8 · 217 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.724 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.425 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.716 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 12.7 · 416 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.6 · 606 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -30.4 · 359 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -31.8 · 555 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -14.4 · 358 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16 · 382 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.1 (3.2 to 8.2) · 25 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.8 (7.3 to 16) · 25 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.5 · 232 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.9 · 56 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 152 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.8 (11.1 to 20) · 251 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 579 cases | No different | Jan 2024 – Dec 2024 |
What patients said (535 patients answered, 18% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Alta Bates Summit Medical Center - Alta Bates Camp
Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 6 the same, 1 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.298 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.18 (0.16 to 2.2) · 730 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.87 (0.51 to 1.23) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 188.12 (132.31 to 243.94) · 50 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 50 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.4 · 189 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.6 · 184 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 103 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 1,585 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.4) · 3,929 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.31 (0.11 to 0.51) · 3,954 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.15 (0.95 to 5.36) · 754 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.62 (0 to 3.33) · 325 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.99 (0.39 to 3.59) · 717 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.85 (2.27 to 19.44) · 326 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.79 (1.08 to 8.49) · 302 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.68 (0.19 to 3.18) · 184 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.17 (0 to 0.88) · 3,240 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 161 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.207 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.48 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.785 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.4 · 243 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -58.2 · 194 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -12.3 · 177 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 209 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.4 (3.8 to 7.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.2 (9.4 to 15.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.8 · 150 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.2 · 81 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.4 (10 to 18.1) · 315 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.2) · 137 cases | No different | Jan 2024 – Dec 2024 |
What patients said (449 patients answered, 15% of those asked)
| Cleanliness | 2 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 62% |
| Nurses "always" communicated well | 72% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 53% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 58% |
| Staff "always" explained new medications | 67% |
| Nurses "always" explained things so they could understand | 67% |
| Nurses "always" listened carefully | 66% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 38% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$79,951
Medicare paid this office $79,951 for 297 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 129 | $20,570 | $104 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 118 | $18,063 | $153 |
| Short return visit (20+ min) | 148 | $12,758 | $72 |
| Sarscov2 vac 50 mcg/0.5ml im | 30 | $4,490 | $150 |
| Long return visit (40+ min) | 22 | $3,928 | $157 |
See all 13 services
| Return visit (30+ min) | 129 | $20,570 | $104 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 118 | $18,063 | $153 |
| Short return visit (20+ min) | 148 | $12,758 | $72 |
| Sarscov2 vac 50 mcg/0.5ml im | 30 | $4,490 | $150 |
| Long return visit (40+ min) | 22 | $3,928 | $157 |
| Sarscv2 vac 30mcg trs-suc im | 17 | $2,573 | $151 |
| Influenza vaccine split virus, preservative free | 31 | $2,569 | $80 |
| Admn sarscov2 vacc 1 dose | 47 | $2,425 | $52 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 69 | $1,509 | $15 |
| New patient visit (45+ min) | 13 | $1,446 | $111 |
| Administration of influenza virus vaccine | 33 | $1,299 | $38 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 14 | $713 | $48 |
| Hemoglobin a1c level | 21 | $276 | $10 |
Who their Medicare patients are
297 Original Medicare patients in 2024. Average age 75 · Under 65 5% · 85 and older 11% · Women 63% · Also on Medicaid 21% · Health risk score 1.03. At or below the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 60% · Depression 21% · Diabetes 19% · Chronic kidney disease 18% · Cancer 16% · Coronary heart disease 12% · Atrial fibrillation 10% · Heart failure 9% · COPD 8% · Dementia 6% · Stroke 4%.
The office billed $255,662, Medicare allowed $100,308 and paid $79,951; for 962 services of 46 kinds; $12,412 of it was for drugs given in the office and $67,539 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 297 | 962 | 75 | 1.03 | $255,662 | $79,951 |
| 2023 | 215 | 475 | 74 | 1.22 | $139,646 | $44,115 |
| 2022 | 351 | 1,012 | 73 | 1.16 | $309,972 | $94,551 |
| 2021 | 265 | 815 | 73 | 1.25 | $267,201 | $72,254 |
| 2020 | 275 | 826 | 73 | 1.55 | $216,267 | $52,496 |
| 2019 | 287 | 890 | 71 | 1.48 | $266,977 | $58,781 |
| 2018 | 216 | 592 | 70 | 1.37 | $162,635 | $40,069 |
| 2017 | 189 | 437 | 70 | 1.15 | $104,385 | $26,207 |
| 2016 | 15 | 22 | 70 | 0.97 | $5,833 | $1,515 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| Return visit (30+ min) | 84 | $10,641 | $106 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 61 | $9,329 | $153 |
| Short return visit (20+ min) | 72 | $6,506 | $81 |
| Long return visit (40+ min) | 22 | $3,621 | $157 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 12 | $3,380 | $282 |
| Influenza vaccine split virus, preservative free | 27 | $1,939 | $72 |
| New patient visit (45+ min) | 13 | $1,499 | $115 |
| Administration of influenza virus vaccine | 30 | $1,089 | $36 |
| Administration of pneumococcal vaccine | 12 | $435 | $36 |
| Hemoglobin a1c level | 11 | $105 | $10 |
2022: 14 services
| Return visit (30+ min) | 165 | $25,743 | $102 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 101 | $15,540 | $154 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 39 | $10,881 | $279 |
| Short return visit (20+ min) | 128 | $10,577 | $70 |
| Long return visit (40+ min) | 53 | $10,549 | $155 |
| New patient visit (45+ min) | 21 | $2,875 | $137 |
| Influenza vaccine split virus, preservative free | 39 | $2,662 | $68 |
| Telephone medical discussion with physician, 11-20 minutes | 30 | $2,333 | $65 |
| Administration of pneumococcal vaccine | 41 | $1,484 | $36 |
| Administration of influenza virus vaccine | 41 | $1,480 | $36 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 23 | $1,418 | $46 |
| Telephone medical discussion with physician, 5-10 minutes | 22 | $1,173 | $45 |
| Adm sarscv2 bvl 30mcg/.3ml a | 17 | $813 | $48 |
| Hemoglobin a1c level | 30 | $355 | $10 |
2021: 15 services
| Return visit (30+ min) | 118 | $20,231 | $106 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 73 | $11,616 | $159 |
| Long return visit (40+ min) | 46 | $9,582 | $152 |
| Short return visit (20+ min) | 95 | $8,419 | $76 |
| Telephone medical discussion with physician, 11-20 minutes | 37 | $4,144 | $70 |
| Telephone medical discussion with physician, 21-30 minutes | 17 | $2,815 | $113 |
| New patient visit (45+ min) | 17 | $2,587 | $152 |
| Influenza vaccine split virus, preservative free | 32 | $2,080 | $65 |
| Telephone medical discussion with physician, 5-10 minutes | 21 | $1,599 | $53 |
| New patient visit (30+ min) | 15 | $1,438 | $96 |
| Pneumococcal vaccine, 23-valent | 11 | $1,361 | $124 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 18 | $1,341 | $52 |
| Administration of influenza virus vaccine | 36 | $784 | $21 |
| Administration of pneumococcal vaccine | 11 | $231 | $21 |
| Hemoglobin a1c level | 16 | $223 | $10 |
2020: 14 services
| Return visit (30+ min) | 96 | $13,403 | $86 |
| Short return visit (20+ min) | 132 | $10,243 | $58 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 53 | $7,467 | $141 |
| Telephone medical discussion with physician, 11-20 minutes | 48 | $5,973 | $66 |
| Telephone medical discussion with physician, 21-30 minutes | 21 | $3,600 | $100 |
| Influenza vaccine split virus, preservative free | 45 | $2,714 | $60 |
| Pneumococcal vaccine, 23-valent | 15 | $1,775 | $118 |
| Telephone medical discussion with physician, 5-10 minutes | 26 | $1,270 | $41 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 19 | $1,124 | $47 |
| Administration of influenza virus vaccine | 49 | $1,006 | $21 |
| New patient visit (30+ min) | 15 | $983 | $66 |
| Administration of pneumococcal vaccine | 17 | $348 | $20 |
| Hemoglobin a1c level | 19 | $193 | $10 |
| Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | 16 | $188 | $12 |
2019: 14 services
| Return visit (30+ min) | 167 | $24,109 | $87 |
| Short return visit (20+ min) | 130 | $9,826 | $59 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 60 | $8,378 | $140 |
| Pneumococcal vaccine, 13-valent | 12 | $2,522 | $210 |
| Influenza vaccine split virus, preservative free | 44 | $2,470 | $55 |
| New patient visit (30+ min) | 28 | $2,000 | $71 |
| Pneumococcal vaccine, 23-valent | 16 | $1,778 | $111 |
| Administration of influenza virus vaccine | 53 | $1,110 | $20 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 12 | $869 | $48 |
| Short return visit | 20 | $835 | $42 |
| Administration of pneumococcal vaccine | 28 | $565 | $20 |
| Hemoglobin a1c level | 20 | $275 | $11 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 16 | $248 | $16 |
| Urinalysis, manual test | 11 | $38 | $3 |
2018: 10 services
| Return visit (30+ min) | 108 | $15,716 | $89 |
| Short return visit (20+ min) | 96 | $6,231 | $57 |
| Pneumococcal vaccine, 13-valent | 20 | $3,971 | $199 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 28 | $3,873 | $138 |
| New patient visit (30+ min) | 26 | $1,980 | $76 |
| Influenza vaccine split virus, preservative free | 36 | $1,879 | $52 |
| Administration of influenza virus vaccine | 44 | $1,113 | $25 |
| Administration of pneumococcal vaccine | 28 | $733 | $25 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 11 | $712 | $51 |
| Urinalysis, manual test | 11 | $38 | $3 |
2017: 6 services
| Return visit (30+ min) | 83 | $12,009 | $88 |
| Short return visit (20+ min) | 96 | $6,361 | $57 |
| New patient visit (30+ min) | 23 | $1,967 | $86 |
| Influenza vaccine split virus, preservative free | 23 | $1,087 | $47 |
| Administration of influenza virus vaccine | 28 | $871 | $31 |
| Urinalysis, manual test | 11 | $38 | $3 |
Medicaid work
$1,781 in 2022
Medicaid paid $1,781 for 39 billed services this clinician did in 2022, up to 14 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 39 | $1,781 |
| 2022 | 39 | 1 | 14 | $1,781 |
| 2021 | 17 | 1 | 16 | $425 |
| 2020 | 148 | 3 | 23 | $4,318 |
| 2019 | 36 | 2 | 12 | $1,269 |
See the largest Medicaid services in earlier years
2021
| Short return visit (20+ min) | 17 | $425 |
2020
| Short return visit (20+ min) | 94 | $2,444 |
| Return visit (30+ min) | 42 | $1,737 |
| Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | 12 | $137 |
2019
| Short return visit (20+ min) | 24 | $682 |
| Return visit (30+ min) | 12 | $587 |
Drugs they prescribed that Part D paid
$117,364
Pharmacies billed $117,364 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 18% of their Part D prescriptions (210 of 1,177) in 2024. A higher opioid share than 9 in 10 peers; the typical family practice clinician is at 2%. Long-acting opioids: 14% of their opioid prescriptions.
1,056 generic and fewer than 11 brand-name prescriptions · $117,364 in drug cost · 39 antibiotic prescriptions to 35 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Hydrocodone-Acetaminophen | 160 | $4,380 | $27 |
| Mirtazapine | 19 | $903 | $48 |
| Valsartan | 13 | $480 | $37 |
| Gabapentin | 33 | $465 | $14 |
| Albuterol Sulfate Hfa | 16 | $387 | $24 |
See all 23 drugs
| Hydrocodone-Acetaminophen | 160 | $4,380 | $27 |
| Mirtazapine | 19 | $903 | $48 |
| Valsartan | 13 | $480 | $37 |
| Gabapentin | 33 | $465 | $14 |
| Albuterol Sulfate Hfa | 16 | $387 | $24 |
| Methadone | 29 | $382 | $13 |
| Rosuvastatin | 12 | $379 | $32 |
| Levothyroxine | 22 | $316 | $14 |
| Atorvastatin | 35 | $283 | $8 |
| Lorazepam | 35 | $234 | $7 |
| Metoprolol | 11 | $227 | $21 |
| Pregabalin | 32 | $156 | $5 |
| Diazepam | 35 | $113 | $3 |
| Ibuprofen | 13 | $111 | $9 |
| Triamcinolone Acetonide | 24 | $107 | $4 |
| Furosemide | 15 | $104 | $7 |
| Zolpidem | 28 | $90 | $3 |
| Amoxicillin-Clavulanate Potass | 14 | $83 | $6 |
| Cyclobenzaprine | 13 | $82 | $6 |
| Hydrochlorothiazide | 18 | $80 | $4 |
| Amlodipine Besylate | 29 | $77 | $3 |
| Losartan | 12 | $72 | $6 |
| Alprazolam | 11 | $41 | $4 |
Year by year
| 2024 | 1,177 | 236 | 18% (210) | None | $117,364 |
| 2023 | 831 | 198 | 15% (126) | None | $117,547 |
| 2022 | 1,497 | 266 | 19% (279) | None | $127,083 |
| 2021 | 1,273 | 241 | 21% (262) | None | $84,411 |
| 2020 | 1,464 | 310 | 15% (219) | None | $77,650 |
| 2019 | 2,302 | 552 | 8% (178) | 15% | $143,255 |
| 2018 | 2,244 | 602 | 8% (177) | 15% | $165,346 |
| 2017 | 801 | 263 | 8% (61) | None | $34,188 |
| 2016 | 119 | 26 | None | 11% | $6,630 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 17 drugs
| Hydrocodone-Acetaminophen | 86 | $2,343 | $27 |
| Gabapentin | 24 | $1,008 | $42 |
| Amlodipine Besylate | 30 | $578 | $19 |
| Atorvastatin | 29 | $481 | $17 |
| Oxycodone-Acetaminophen | 14 | $462 | $33 |
| Levothyroxine | 21 | $421 | $20 |
| Losartan | 15 | $327 | $22 |
| Lisinopril | 20 | $325 | $16 |
| Metformin | 19 | $283 | $15 |
| Methadone | 14 | $275 | $20 |
| Pregabalin | 12 | $254 | $21 |
| Celecoxib | 11 | $222 | $20 |
| Sertraline | 11 | $174 | $16 |
| Diazepam | 21 | $162 | $8 |
| Zolpidem | 13 | $97 | $7 |
| Simvastatin | 12 | $56 | $5 |
| Hydrochlorothiazide | 20 | $53 | $3 |
2022: 36 drugs
| Hydrocodone-Acetaminophen | 182 | $4,635 | $25 |
| Fentanyl | 13 | $3,064 | $236 |
| Mirtazapine | 25 | $902 | $36 |
| Albuterol Sulfate Hfa | 19 | $859 | $45 |
| Losartan | 43 | $815 | $19 |
| Oxycodone-Acetaminophen | 31 | $793 | $26 |
| Pregabalin | 18 | $774 | $43 |
| Atorvastatin | 40 | $649 | $16 |
| Rosuvastatin | 13 | $601 | $46 |
| Amlodipine Besylate | 36 | $527 | $15 |
| Diclofenac | 15 | $489 | $33 |
| Gabapentin | 15 | $420 | $28 |
| Levothyroxine | 23 | $418 | $18 |
| Lisinopril | 39 | $407 | $10 |
| Famotidine | 16 | $380 | $24 |
| Methadone | 17 | $338 | $20 |
| Pantoprazole | 12 | $333 | $28 |
| Montelukast | 26 | $327 | $13 |
| Zolpidem | 28 | $315 | $11 |
| Trazodone | 17 | $306 | $18 |
| Metoprolol | 17 | $305 | $18 |
| Sertraline | 23 | $275 | $12 |
| Metformin Hcl Er | 15 | $209 | $14 |
| Fluticasone Propionate | 12 | $195 | $16 |
| Lorazepam | 28 | $185 | $7 |
| Hydrochlorothiazide | 33 | $183 | $6 |
| Clonazepam | 20 | $180 | $9 |
| Simvastatin | 25 | $178 | $7 |
| Metformin | 17 | $171 | $10 |
| Cyclobenzaprine | 16 | $167 | $10 |
| Escitalopram | 12 | $144 | $12 |
| Diazepam | 40 | $131 | $3 |
| Tramadol | 21 | $130 | $6 |
| Furosemide | 15 | $94 | $6 |
| Atenolol | 11 | $92 | $8 |
| Cephalexin | 11 | $54 | $5 |
2021: 30 drugs
| Hydrocodone-Acetaminophen | 176 | $4,448 | $25 |
| Fentanyl | 14 | $2,036 | $145 |
| Celecoxib | 12 | $870 | $73 |
| Levothyroxine | 41 | $827 | $20 |
| Atorvastatin | 47 | $820 | $17 |
| Mirtazapine | 15 | $719 | $48 |
| Ventolin Hfa | 12 | $670 | $56 |
| Gabapentin | 23 | $663 | $29 |
| Pregabalin | 11 | $516 | $47 |
| Cyclobenzaprine | 18 | $450 | $25 |
| Oxycodone-Acetaminophen | 14 | $435 | $31 |
| Escitalopram | 13 | $431 | $33 |
| Amlodipine Besylate | 50 | $429 | $9 |
| Duloxetine | 12 | $419 | $35 |
| Metformin Hcl Er | 20 | $403 | $20 |
| Methadone | 21 | $344 | $16 |
| Lorazepam | 28 | $332 | $12 |
| Losartan | 17 | $301 | $18 |
| Trazodone | 19 | $292 | $15 |
| Omeprazole | 12 | $205 | $17 |
| Simvastatin | 18 | $181 | $10 |
| Metformin | 22 | $162 | $7 |
| Lisinopril | 15 | $115 | $8 |
| Hydrochlorothiazide | 26 | $99 | $4 |
| Diazepam | 20 | $76 | $4 |
| Zolpidem | 11 | $76 | $7 |
| Atenolol | 14 | $73 | $5 |
| Cephalexin | 12 | $63 | $5 |
| Clonazepam | 14 | $61 | $4 |
| Tramadol | 15 | $30 | $2 |
2020: 34 drugs
| Hydrocodone-Acetaminophen | 139 | $2,963 | $21 |
| Fentanyl | 12 | $1,560 | $130 |
| Levothyroxine | 72 | $1,410 | $20 |
| Atorvastatin | 50 | $1,070 | $21 |
| Propranolol | 12 | $744 | $62 |
| Metoprolol | 23 | $740 | $32 |
| Bupropion Xl | 15 | $701 | $47 |
| Ventolin Hfa | 12 | $691 | $58 |
| Albuterol Sulfate Hfa | 11 | $624 | $57 |
| Estradiol | 14 | $570 | $41 |
| Diclofenac | 17 | $517 | $30 |
| Simvastatin | 44 | $463 | $11 |
| Acetaminophen-Codeine | 31 | $413 | $13 |
| Lisinopril | 41 | $394 | $10 |
| Gabapentin | 24 | $370 | $15 |
| Losartan | 32 | $348 | $11 |
| Lorazepam | 40 | $298 | $7 |
| Hydrochlorothiazide | 37 | $291 | $8 |
| Baclofen | 16 | $277 | $17 |
| Amlodipine Besylate | 44 | $270 | $6 |
| Metformin | 27 | $219 | $8 |
| Pantoprazole | 13 | $217 | $17 |
| Trazodone | 13 | $206 | $16 |
| Omeprazole | 13 | $184 | $14 |
| Montelukast | 16 | $160 | $10 |
| Diazepam | 26 | $159 | $6 |
| Enalapril Maleate | 15 | $155 | $10 |
| Fluticasone Propionate | 13 | $153 | $12 |
| Methadone | 14 | $136 | $10 |
| Zolpidem | 21 | $118 | $6 |
| Atenolol | 13 | $116 | $9 |
| Cephalexin | 12 | $61 | $5 |
| Clonazepam | 13 | $58 | $4 |
| Tramadol | 15 | $38 | $3 |
2019: 47 drugs
| Basaglar Kwikpen U-100 | 21 | $5,127 | $244 |
| Levothyroxine | 110 | $2,733 | $25 |
| Hydrocodone-Acetaminophen | 116 | $2,413 | $21 |
| Atorvastatin | 105 | $2,281 | $22 |
| Estradiol | 22 | $1,593 | $72 |
| Gabapentin | 63 | $1,560 | $25 |
| Duloxetine | 11 | $1,422 | $129 |
| Metoprolol | 29 | $1,242 | $43 |
| Ventolin Hfa | 19 | $1,201 | $63 |
| Lisinopril | 93 | $889 | $10 |
| Fluticasone Propionate | 45 | $764 | $17 |
| Simvastatin | 64 | $676 | $11 |
| Amlodipine Besylate | 107 | $670 | $6 |
| Baclofen | 14 | $564 | $40 |
| Hydrochlorothiazide | 83 | $551 | $7 |
| Losartan | 53 | $550 | $10 |
| Albuterol Sulfate Hfa | 12 | $537 | $45 |
| Pravastatin | 17 | $480 | $28 |
| Metformin | 47 | $442 | $9 |
| Potassium Chloride | 12 | $417 | $35 |
| Tamsulosin | 18 | $398 | $22 |
| Terazosin | 12 | $382 | $32 |
| Montelukast | 19 | $381 | $20 |
| Clotrimazole | 13 | $336 | $26 |
| Omeprazole | 28 | $332 | $12 |
| Promethazine | 13 | $312 | $24 |
| Pantoprazole | 23 | $306 | $13 |
| Sumatriptan | 11 | $291 | $26 |
| Nystatin | 13 | $283 | $22 |
| Alendronate | 28 | $257 | $9 |
| Fluoxetine | 11 | $254 | $23 |
| Glipizide | 19 | $246 | $13 |
| Triamcinolone Acetonide | 22 | $237 | $11 |
| Sertraline | 18 | $228 | $13 |
| Olanzapine | 11 | $209 | $19 |
| Zolpidem | 21 | $205 | $10 |
| Atenolol | 18 | $195 | $11 |
| Carvedilol | 19 | $193 | $10 |
| Ibuprofen | 27 | $185 | $7 |
| Acetaminophen-Codeine | 18 | $173 | $10 |
| Trazodone | 22 | $162 | $7 |
| Lorazepam | 16 | $151 | $9 |
| Diazepam | 18 | $149 | $8 |
| Furosemide | 18 | $142 | $8 |
| Lovastatin | 14 | $133 | $9 |
| Methadone | 11 | $107 | $10 |
| Metoprolol | 14 | $92 | $7 |
2018: 56 drugs
| Advair Diskus | 24 | $12,075 | $503 |
| Lantus Solostar | 15 | $6,986 | $466 |
| Spiriva | 13 | $6,016 | $463 |
| Hydrocodone-Acetaminophen | 115 | $3,172 | $28 |
| Ventolin Hfa | 38 | $2,545 | $67 |
| Levothyroxine | 88 | $2,297 | $26 |
| Theophylline Anhydrous | 11 | $1,945 | $177 |
| Atorvastatin | 88 | $1,911 | $22 |
| Gabapentin | 51 | $1,762 | $35 |
| Polyethylene Glycol 3350 | 17 | $1,449 | $85 |
| Metoprolol | 33 | $1,404 | $43 |
| Bupropion Xl | 12 | $1,170 | $97 |
| Proair Hfa | 14 | $888 | $63 |
| Valsartan | 16 | $656 | $41 |
| Pravastatin | 23 | $652 | $28 |
| Amitriptyline | 11 | $644 | $59 |
| Amlodipine Besylate | 99 | $642 | $6 |
| Lisinopril | 65 | $619 | $10 |
| Simvastatin | 63 | $568 | $9 |
| Hydrochlorothiazide | 97 | $545 | $6 |
| Potassium Chloride | 22 | $533 | $24 |
| Losartan | 44 | $479 | $11 |
| Fluticasone Propionate | 30 | $475 | $16 |
| Fluoxetine | 20 | $461 | $23 |
| Omeprazole | 25 | $432 | $17 |
| Glipizide | 22 | $350 | $16 |
| Trazodone | 35 | $315 | $9 |
| Metformin | 29 | $295 | $10 |
| Baclofen | 12 | $292 | $24 |
| Atenolol | 24 | $282 | $12 |
| Chlorthalidone | 12 | $257 | $21 |
| Acetaminophen-Codeine | 15 | $234 | $16 |
| Alendronate | 22 | $229 | $10 |
| Clonazepam | 17 | $217 | $13 |
| Escitalopram | 16 | $213 | $13 |
| Cyclobenzaprine | 14 | $198 | $14 |
| Sertraline | 22 | $198 | $9 |
| Metformin Hcl Er | 19 | $194 | $10 |
| Lorazepam | 16 | $180 | $11 |
| Levetiracetam | 12 | $177 | $15 |
| Lovastatin | 16 | $176 | $11 |
| Triamcinolone Acetonide | 18 | $173 | $10 |
| Diazepam | 25 | $165 | $7 |
| Zolpidem | 17 | $159 | $9 |
| Ibuprofen | 20 | $150 | $8 |
| Paroxetine | 13 | $138 | $11 |
| Carvedilol | 13 | $138 | $11 |
| Losartan-Hydrochlorothiazide | 13 | $126 | $10 |
| Pantoprazole | 16 | $118 | $7 |
| Furosemide | 19 | $102 | $5 |
| Donepezil | 13 | $101 | $8 |
| Clonidine | 13 | $90 | $7 |
| Citalopram Hbr | 11 | $86 | $8 |
| Azithromycin | 11 | $62 | $6 |
| Tramadol | 12 | $61 | $5 |
| Metoprolol | 12 | $52 | $4 |
2017: 20 drugs
| Ventolin Hfa | 23 | $1,233 | $54 |
| Atorvastatin | 32 | $731 | $23 |
| Proair Hfa | 12 | $678 | $56 |
| Gabapentin | 20 | $676 | $34 |
| Levothyroxine | 21 | $570 | $27 |
| Hydrocodone-Acetaminophen | 30 | $469 | $16 |
| Levetiracetam | 18 | $296 | $16 |
| Fluticasone Propionate | 11 | $194 | $18 |
| Omeprazole | 20 | $191 | $10 |
| Trazodone | 14 | $160 | $11 |
| Losartan | 19 | $131 | $7 |
| Lisinopril | 27 | $124 | $5 |
| Metformin | 16 | $123 | $8 |
| Amlodipine Besylate | 22 | $119 | $5 |
| Sertraline | 11 | $104 | $9 |
| Ibuprofen | 12 | $61 | $5 |
| Tramadol | 11 | $56 | $5 |
| Furosemide | 16 | $51 | $3 |
| Triamcinolone Acetonide | 13 | $46 | $4 |
| Hydrochlorothiazide | 12 | $36 | $3 |
Money from drug and device companies
$157 in 2022
A payment is not proof that care is biased.
| Novo Nordisk | Saxenda | $114 | 1 payment
|
| Sanofi Pasteur | Fluzone Quadrivalent Northern Hemisphere | $26 | 1 payment
|
| Hologic | Aptima | $17 | 1 payment
|
See all 3 published payments
| Novo Nordisk | Meals · 2022-08-10 | Saxenda | $114 |
| Sanofi Pasteur | Meals · 2022-08-03 | Fluzone Quadrivalent Northern Hemisphere | $26 |
| Hologic | Meals · 2022-07-20 | Aptima | $17 |
Professional record
- NPI
- 1699198564
- Licence
- CA A140160California A140160: Current · expires 2027-10-31
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 5915 Hollis St Ste B, Emeryville, CA, 94608
- NPI first listed
- 2014-01-29
- NPI last updated
- 2024-04-25
- NPI record certified
- 2024-04-25
This is when the NPI record was last certified, not a medical board exam.